Jianhong Zeng

Ms. Jianhong Zeng


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2025 in AMB Express
Verified
Journal Article
Open access
PDF file
YLYunli Li
Yunli Li
JWJianzhao Wu
Jianzhao Wu
JLJiaqi Li
Jiaqi Li
JZJianhong Zeng
Jianhong Zeng
LLLi Lin
Li Lin
SLSongrui Liu
Songrui Liu
Canine distemper virus (CDV) is a multi-host pathogen with high morbidity and mortality, posing a severe threat to endangered carnivores, including giant p

4 November 2026 in Antibodies
Verified
Journal Article
Open access
PDF file
YLYunli Li
Yunli Li
QLQiaoli Lang
Qiaoli Lang
JZJianhong Zeng
Jianhong Zeng
WWWei Wang
Wei Wang
HZHongwen Zhang
Hongwen Zhang
SLSongrui Liu
Songrui Liu
Background/Objectives: Canine distemper virus (CDV) poses a major threat to the conservation of the endangered giant panda (Ailuropoda melanoleuca). Although monoclonal antibodies hold great therapeutic promise, the development of species-specific antibody therapeutics for wildlife remains challenging. In this study, we aimed to construct and optimize a giant panda chimeric antibody targeting the CDV H protein through Fc engineering. Methods: A chimeric antibody (6G4-gpIgG1) was constructed by fusing the variable regions of a murine anti-CDV H antibody with giant panda IgG1b Fc. Structural analysis using AlphaFold identified excessive hinge exposure as a potential cause of instability. A C226S mutation in the hinge region was designed and introduced. The wild-type and mutant antibodies were expressed in CHO-S cells, purified, and characterized by SDS-PAGE, ELISA, biolayer interferometry (BLI), and SEC-HPLC. Results: The wild-type murine–giant panda chimeric antibody exhibited degradation fragmentation and a nanomolar-range binding affinity (EC50 = 0.62 nM; BLI KD = 4.27 × 10−9 M). The C226S mutation (6G4-gpIgG1-Opt2) reduced fragmentation, increased monomer purity from 88.38% to 96.99%, and increased antigen-binding activity by over 30-fold (EC50 = 0.019 nM), reaching levels comparable to the murine–canine chimeric control, which exhibited a canonical Y-shaped conformation. BLI also revealed stronger binding affinity for Opt2 (KD = 1.33 × 10−10 M), associated with a slower dissociation rate (kdis = 7.80 × 10−5 s−1 versus 1.15 × 10−3 s−1 for the wild type). Conclusions: A single C226S mutation in the giant panda IgG1 hinge region substantially improves structural stability, reducing degradation fragments, increasing monomer purity, and unexpectedly enhancing antigen-binding affinity by over 30-fold. This study provides a structure-guided Fc engineering strategy for developing chimeric antibodies in giant pandas, offering a promising candidate for CDV protection and a generalizable framework for conservation medicine.